Head & Neck cancer
Researchers estimate that 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older in 2011 were attributable to cigarette smoking, according to a newly published study.
Survival more likely with adherence to posttreatment surveillance, coupled with tobacco cessation.
Sunitinib (Sutent), a drug approved for treatment of several other cancers, may be an effective adjunctive treatment for patients with advanced differentiated thyroid cancer.
Investigators have uncovered genomic differences, with potentially important clinical implications, in head and neck cancers caused by infection with the human papillomavirus.
By utilizing both facial scanning software and 3-D printing, researchers have developed an inexpensive way to make facial prostheses for patients with eye cancer.
Hyperfractionated radiation therapy may increase local-regional control for patients with head and neck cancerJune 04, 2014
The survival of patients with head and neck squamous cell carcinoma can be affected by noncancer health events as well as by index cancer progression and second primary cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|